| Contributors |
|
v | |
| List of special reviews |
|
xv | |
| Cumulative index of special reviews |
|
xvii | |
| How to use this book |
|
xxiii | |
| Historical Essay: From thalidomide to pharmacovigilance: a personal account |
|
xxv | |
|
|
|
| Essay: How safe is cannabis? |
|
xxxiii | |
|
|
|
| 1. Central nervous system stimulants and drugs that suppress appetite |
|
1 | (10) |
|
|
|
| 2. Antidepressant drugs |
|
11 | (8) |
|
|
|
| 3. Lithium |
|
19 | (11) |
|
|
|
| 4. Drugs of abuse |
|
30 | (16) |
|
|
|
| 5. Hypnosedatives and anxiolytics |
|
46 | (7) |
|
|
|
| 6. Antipsychotic drugs |
|
53 | (17) |
|
A. Carvajal and L.H.M. Arias |
|
|
| 7. Antiepileptic drugs |
|
70 | (19) |
|
|
|
| 8. Opioid analgesics and narcotic antagonists |
|
89 | (22) |
|
A.H. Ghodse and A.M. Baldacchino |
|
|
| 9. Anti-inflammatory and antipyretic analgesics and drugs used in gout |
|
111 | (20) |
|
|
|
| 10. General anesthetics and therapeutic gases |
|
131 | (9) |
|
|
|
| 11. Local anesthetics |
|
140 | (10) |
|
S.A. Schug, G. Gillespie, and K.J.D. Stannard |
|
|
| 12. Neuromuscular blocking agents and skeletal muscle relaxants |
|
150 | (6) |
|
|
|
| 13. Drugs that affect autonomic functions or the extrapyramidal system |
|
156 | (12) |
|
|
|
| 14. Dermatological drugs and topical agents |
|
168 | (12) |
|
WM. C. Mulder and M.M.H.M. Meinardi |
|
|
| 15. Antihistamines (H1 receptor antagonists) |
|
180 | (6) |
|
|
|
| 16. Drugs acting on the respiratory tract |
|
186 | (12) |
|
M. Kuhn, M. Joerger, and K. Hartmann |
|
|
| 17. Positive inotropic drugs and drugs used in dysrhythmias |
|
198 | (25) |
|
|
|
| 18. Beta-adrenoceptor antagonists and antianginal drugs |
|
223 | (7) |
|
A.P. Maggioni, M.G. Franzosi, and R. Latini |
|
|
| 19. Drugs acting on the cerebral and peripheral circulations |
|
230 | (3) |
|
|
|
| 20. Antihypertensive drugs |
|
233 | (5) |
|
|
|
| 21. Diuretics |
|
238 | (5) |
|
|
|
| 22. Metals |
|
243 | (10) |
|
G.B. van der Voet and F.A. de Wolff |
|
|
| 23. Metal antagonists |
|
253 | (5) |
|
|
|
| 24. Antiseptic drugs and disinfectants |
|
258 | (4) |
|
|
|
| 25. Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines |
|
262 | (9) |
|
|
|
| 26. Miscellaneous antibacterial drugs |
|
271 | (31) |
|
|
|
| 27. Antifungal drugs |
|
302 | (13) |
|
A.H. Groll and T.J. Walsh |
|
|
| 28. Antiprotozoal drugs |
|
315 | (13) |
|
T. Bicanic, T. Planche, and S. Krishna |
|
|
| 29. Antiviral drugs |
|
328 | (11) |
|
|
|
| 30. Drugs used in tuberculosis and leprosy |
|
339 | (5) |
|
|
|
| 31. Antihelminthic drugs |
|
344 | (9) |
|
|
|
| 32. Vaccines |
|
353 | (10) |
|
|
|
| 33. Blood, blood components, plasma, and plasma products |
|
363 | (11) |
|
P.J.M. Vossebeld, H.W. Eijkhout, and W.G. van Aken |
|
|
| 34. Intravenous infusions-solutions and emulsions |
|
374 | (5) |
|
|
|
| 35. Drugs affecting blood coagulation, fibrinolysis, and hemostasis |
|
379 | (3) |
|
K. Peerlinck and J. Vermylen |
|
|
| 36. Gastrointestinal drugs |
|
382 | (11) |
|
|
|
| 37. Drugs acting on the immune system |
|
393 | (23) |
|
T. Vial, J. Descotes, G. Screaton, M. Behrend, and C. Ludwig |
|
|
| 38. Vitamins |
|
416 | (11) |
|
|
|
| 39. Corticotrophins, corticosteroids, and prostaglandins |
|
427 | (7) |
|
|
|
| 40. Sex hormones and related compounds, including hormonal contraceptives |
|
434 | (23) |
|
|
|
| 41. Thyroid hormones and antithyroid drugs |
|
457 | (4) |
|
|
|
| 42. Insulin, glucagon, and hypoglycemic drugs |
|
461 | (16) |
|
|
|
| 43. Miscellaneous hormones |
|
477 | (9) |
|
|
|
| 44. Drugs that affect lipid metabolism |
|
486 | (4) |
|
|
|
| 45. Cytostatic drugs |
|
490 | (22) |
|
H.-P. Lipp, C. Bokemeyer, J.T. Hartmann, and A. Stanley |
|
|
| 46. Radiological contrast agents |
|
512 | (13) |
|
|
|
| 47. Drugs used in ocular treatment |
|
525 | (3) |
|
|
|
| 48. Treatments used in complementary and alternative medicine |
|
528 | (12) |
|
|
|
| 49. Miscellaneous drugs, materials, and medical devices |
|
540 | (8) |
|
|
|
| 50. The WHO International Drug Monitoring Programme |
|
548 | (11) |
|
L.R. Edwards and S. Olsson |
|
|
| Address list of national centres that participate in the WHO Drug Monitoring Programme |
|
559 | |
| Index of drugs |
|
xxx | |
| Index of adverse effects |
|
xxx | |